What is Pharmacoepidemiology?

Textbook of Pharmacoepidemiology, Third Edition

Volumn , Issue , 2021, Pages 3-19

  Strom, Brian L ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

clinical pharmacology; drug regulation; European Medicines Agency; pharmacodynamics; pharmacoepidemiology; pharmacokinetics

Indexed keywords

EID: 85160175986     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781119701101.ch1     Document Type: Chapter

References (20)

1. Califf, R.M. (2002). The need for a national infrastructure to improve the rational use of therapeutics. Pharmacoepidemiol. Drug Saf. 11: 319-327
2. Caranasos, G.J., Stewart, R.B., and Cluff, L.E. (1974). Drug-induced illness leading to hospitalization. JAMA 228: 713-717
3. Cluff, L.E., Thornton, G.F., and Seidl, L.G. (1964). Studies on the epidemiology of adverse drug reactions I. Methods of surveillance. JAMA 188: 976-983
4. Crane, J., Pearce, N., Flatt, A. et al. (1989). Prescribed fenoterol and death from asthma in New Zealand, 1981-1983: case-control study. Lancet 1: 917-922
5. Erslev, A.J. and Wintrobe, M.M. (1962). Detection and prevention of drug induced blood dyscrasias. JAMA 181: 114-119
6. Geiling, E.M.K. and Cannon, P.R. (1938). Pathogenic effects of elixir of sulfanilamide (diethylene glycol) poisoning. JAMA 111: 919-926
7. Herbst, A.L., Ulfelder, H., and Poskanzer, D.C. (1971). Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N. Engl. J. Med. 284: 878-881
8. ISPE (2008). Guidelines for good pharmacoepidemiology practices (GPP). Pharmacoepidemiol. Drug Saf. 17: 200-208
9. Joint Commission on Prescription Drug Use (1980) Final Report. Washington, DC
10. Kimmel, S.E., Keane, M.G., Crary, J.L. et al. (1999). Detailed examination of fenfluramine-phentermine users with valve abnormalities identified in Fargo, North Dakota. Am. J. Cardiol. 84: 304-308
11. Kono, R. (1980). Trends and lessons of SMON research. In: Drug-Induced Sufferings (ed. T. Soda), 11. Princeton, NJ: Excerpta Medica
12. Lazarou, J., Pomeranz, B.H., and Corey, P.N. (1998). Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279: 1200-1205
13. Lenz, W. (1966). Malformations caused by drugs in pregnancy. Am. J. Dis. Child. 112: 99-106
14. Meyler, L. (1952). Side Effects of Drugs. Amsterdam: Elsevier
15. Miller, R.R. and Greenblatt, D.J. (1976). Drug Effects in Hospitalized Patients. New York: John Wiley & Sons, Inc
16. Rawlins, M.D. and Thompson, J.W. (1977). Pathogenesis of adverse drug reactions. In: Textbook of Adverse Drug Reactions (ed. D.M. Davies), 44. Oxford: Oxford University Press
17. Strom, B.L. (1990). Members of the ASCPT pharmacoepidemiology section. Position paper on the use of purported postmarketing drug surveillance studies for promotional purposes. Clin. Pharmacol. Ther. 48: 598
18. Strom, B.L., Berlin, J.A., Kinman, J.L. et al. (1996). Parenteral ketorolac and risk of gastrointestinal and operative site bleeding: a postmarketing surveillance study. JAMA 275: 376-382
19. Wallerstein, R.O., Condit, P.K., Kasper, C.K. et al. (1969). Statewide study of chloramphenicol therapy and fatal aplastic anemia. JAMA 208: 2045-2050
20. Wright, P. (1975). Untoward effects associated with practolol administration. Oculomucocutaneous syndrome. BMJ 1: 595-598